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Abstract
Brain tumor resection in pediatric patients constitutes a real challenge. In order 
to improve survival and to preserve neurological function, we will further on 
describe our experience with awake craniotomy and functional mapping for brain 
tumor resection in pediatric patients. Although our experience with this technique 
was relatively short, we did not observe complications, and a gross total resection 
was successfully achieved in all cases. In the postoperative period we did not find 
any new deficiency in our patients. We observed functional recovery - motor and 
sensitive aphasia, motor strength improvement in hemiplegic patients, and recov-
ery of neurodevelopmental milestones during follow-up. In our experience, the 
use of awake craniotomy and brain mapping for brain tumor resection in pediatric 
patients is truly safe and reliable.
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1. Introduction
The last year, the Instituto Nacional de Pediatría at Mexico is commemorating the 
50th anniversary of its foundation. Throughout the years, the Pediatric Neurosurgery 
Department has consolidated itself as an emblematic service in our hospital among 
the civilian population and has become the reference center in Mexico to treat brain 
tumors and complex neurosurgical diseases.
The Centro Médico Naval is the referral center for the treatment of complex 
neurosurgical diseases in the health services of the Secretaría de Marina of Mexico. 
We serve military personnel and their families, as well as civilian population under 
certain public health circumstances, as COVID-19 pandemic. The Neurosurgery 
Department is equipped with the ultimate technological devices for brain tumor 
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treatment, such as neuronavigational systems (Brainlab and Medtronic Systems), 
intraoperative imaging devices (O-arm), neurophysiological equipment for brain 
mapping and subcortical stimulation.
This review describes our protocol in both centers for Awake craniotomy and 
brain mapping for brain tumor resection in pediatric patients.
In recent years, the collaborative work performed by an experienced group of 
neuroscientific specialties - Neuroanesthesiologist (LAE, NOG), Neuropsychologist 
(BAM, RAS, CA), Neurophysiologist (LMC/DMR), and a specialist from the 
Intensive care unit (SLL) and pediatric oncologist (AN); allows us to treat brain 
tumors located in eloquent areas in young brains.
2. Neuropsychological evaluation
Most neurological diseases have variable expressiveness; the severity of symp-
toms that define the disorder varies between individuals. The variability of symp-
tom expression should be identified, and the expected effects of treatment defined. 
The neurological pathology is complex and comprises a set of unique conditions, 
therefore it is required a multidisciplinary team of professionals and specialists in 
pediatric neurosurgery and neuropsychology.
Neuropsychological pediatric evaluation faces certain peculiarities. The 
brain’s functional systems are in development. Thus, certain functions are not 
able to be properly evaluated. The neuropsychological evaluation tries to obtain 
a capacity profile which contains weak and strong points. When certain neuro-
psychological abilities (behavioral and cognitive) are selectively impaired, they 
may be compatible with the neurological alteration detected. The purpose of an 
evaluation depends mainly on the reference reason, and this, in turn, depends on 
the patient’s age, academic grade and cognitive development. Neuropsychological 
tests are essential for establishing a cognitive disorder; in a patient with a brain 
tumor, it is crucial to have several chronologically ordered evaluations. All 
improvements can also be monitored by repeating a series of tests, and changes 
in symptomatology can be detected early. Furthermore, the intervention’s effec-
tiveness can be documented, and neuropsychological rehabilitation interventions 
can be scheduled.
Concerning tumors, the tumor growth site does often relate to neuropsycho-
logical deficits (e.g., left hemisphere tumors often affect language). However, due 
to compression and displacement effects, more widespread damage and overall 
neuropsychological impairment may occur [1].
It is essential to mention that neuropsychological functions result from a 
complex functional system that cannot be located in restricted areas of the cerebral 
cortex or isolated cells. With the use of such specific MRI techniques as blood 
oxygenation level dependent imaging (BOLD), we know that those functions must 
be organized into systems of areas that work harmoniously, each of which plays its 
part within the complex functional system, being located in entirely different areas 
often very distant from each other in the brain.
Neuropsychological functioning is related to tumor malignancy and behavior; 
neuropsychological performance assessment may be more sensitive in predicting 
early tumor recurrence than imaging techniques [1].
In recent years, there has been an increase in the need for neuropsychological 
evaluations in people who have suffered from known organic diseases and psy-
chiatric pathologies where brain dysfunction is suspected. Interestingly, in most 
western countries, there has been a crescent incorporation of neuropsychologists 
into hospital services.
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The neuropsychological assessment’s primary objective is to identify a pos-
sible alteration of functions which are regulated by the cerebral cortex and 
powerful neuropsychological interventions during sequelae early identification 
and treatment [2].
When someone faces the need to perform a neuropsychological evaluation, they 
deal with people who retain a very diverse set of skills depending on their personal-
ity characteristics, disease topography, brain edema. These conditions prevent the 
talk of a rigid evaluation protocol and a set of tests established in advance; they 
require, on the other hand, a certain level of knowledge to determine in each case 
the most appropriate evaluation tests [2].
The neuropsychological evaluation has been used during surgeries such as 
epilepsy and deep brain stimulation to identify adverse outcome risks. The results 
of this evaluation represent the starting point for neuropsychological treatment and 
rehabilitation [3].
In a pediatric patient with a brain tumor, the neuropsychological evaluation is 
performed to determine the patient’s overall cognitive status, specifying the skills 
preserved in contrast with those affected by brain edema and destruction of tissue 
secondary to the tumor [4, 5].
To set up the overall cognitive status of the patient before surgery, it requires the 
application of specific instruments, including standardized batteries, or a set of tests 
which adapt to the specific problems and needs of each patient; allowing to establish:
a. Preserved and altered cognitive functions, i.e., a baseline against which to 
evaluate postoperative function.
b. The ability of patients to cooperate with transoperative and postoperative needs.
The role of the Neuropsychologist in CNS surgery is divided into different 
stages. The preoperative evaluation aims to locate, if possible, the focus by asso-
ciating cognitive deficits in a particular brain region. Set a baseline for measur-
ing changes. Predict cognitive risks after surgery and, in conjunction with the 
neurosurgeon and family members, assess the procedure’s risks/benefits in their 
quality of life. It is useful as a guide to the neurosurgeon to decide which areas of 
the brain are at risk and adjust, from there, educational and cognitive rehabilitation 
programs. Finally, the evaluation can help diagnose psychiatric disorders and their 
potential impact on cooperation in the operating room. Several reports note that 
much of the success of awake patient surgery is due to the patient’s active participa-
tion in the intraoperative process. During functional testing, patient cooperation 
allows the team to make real-time surgical decisions to achieve maximum tumor 
resection with minimal functional deterioration to ensure a better quality of life.
There is no protocolized structure for neuropsychological exploration and 
monitoring that these patients need; there is not enough information about 
candidates’ psychological profiles and eligibility criteria. The transoperative 
evaluation is based on the literature on the Wada test’s use, mainly evaluating 
language and memory in the dominant hemisphere.
The evaluation depends on the patient’s cooperation and what can be applied; if 






• Repetition of sentences
• Oral reading (if possible)




• Repetition of digits
• Calculation
Already standardized test subtests measure these areas such as Wechsler Scales, 
Luria test, Woodkock test, a word list with a letter. These tests are appropriate for 
the child’s age and the evaluation context.
Postoperative evaluation allows monitoring of its evolution, possible sequelae, 
and the creation of stimulation programs to achieve its full potential.
It has been estimated that there are transient changes in cognitive functioning 
within the first three months of post-surgical recovery, which are relatively permanent 
within the following six months after the intervention. However, the most significant 
changes can occur up to one year after the intervention.
3. Neuroanesthesiological evaluation
Several anesthetic considerations for awake craniotomy should be granted to 
avoid injuries in brain surgery. The primary goal is to carry out the lesion’s resection 
with maximum preservation of neurological functions [6, 7]. This type of manage-
ment in pediatric patients is limited by anxiety and insufficient understanding, 
limiting their cooperation during the procedure [8].
The awake craniotomy technique had been developing since the second half of 
the 19th century when local anesthetics (LA) became widely available. With proper 
local analgesia, Prof. Horace Horsley was able to perform a craniotomy in awake 
patients. The benefits were not recognized until 1951, when Prof. Wilder Penfield 
published LA value for craniotomy in patients with epilepsy to facilitate the resection 
of epileptogenic focuses [9].
Prof. Penfield argumented that patients with functional neurological pathology 
should be operated on awake modality and at the same time performing complex 
and motor activities.
It was initially designed for patients undergoing functional neurological surgery. 
It is currently offered in pathologies that involve eloquent or motor areas, where 
real-time monitoring of superior or motor functions is required during tumor 
resection [10].
The anesthesiologist should know the problems faced during the brain tumor 
resection in the awake patient, should be aware that at any time, surgery can be 
switched to a classic craniotomy under total endovenous anesthesia [11].
Scenarios that may be confronted during both phases, asleep or awake, are sei-
zures or movements typical of the patient, result of the suboptimal neuromuscular 
blockage, or movements in the presence of anxiety or insufficient analgesia. These 
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symptoms can result in severe damage, from lacerations to the scalp, skull fractures, 
including cervical spine injuries [9]. This technique aims to provide the neurosur-
geon tools to perform the lesion’s resection with maximum preservation of eloquent 
or motor anatomical areas, preserve the patient’s integrity, minimize neurologi-
cal damage and not to increase the deficit already installed [7, 8]. This technique 
involves inducing general anesthesia and maintaining airway control with a supra-
glottic device, it also includes invasive monitoring (catheter placement and urinary 
catheter), administration of scalp blockage, patient positioning, including fixing 
the skull to Mayfield’s head clamp to opening the dura mater [9, 10].
The technique consists of awakening the patient, ousting the supraglottic device, 
and performing cortical mapping or delimitation of the lesion and resection. At the 
end of the resection, general anesthesia is again continued, the supraglottic device 
is reinserted, and the dura mater, skull, and skin are closed.
The main objective of anesthetic management is to ensure adequate patient coop-
eration, maintain comfort throughout the procedure concerning the chosen position 
for surgery, prevent and treat nausea, vomiting, seizures, and maintain systemic and 
neurological homeostasis to provide adequate ventilation, hemodynamic stability, 
and brain relaxation [11].
Optimal tumor resection is maximum mass removal without significant neu-
rological deficits, such as damage to motor or language function. Therefore, it is 
now considered the treatment of choice for brain tumor surgery in eloquent areas. 
Compared to craniotomy under general anesthesia, an awake craniotomy may pro-
vide a higher degree of tumor removal without postoperative neurological deficits 
and better survival rates in these patients [12].
The pediatric patient represents a tremendous challenge for the awake craniotomy 
technique’s success. The cognitive level and emotional maturity will determine their 
cooperation during the procedure. It is well known that the patient under the age 
of 16 does not yet have an adult’s maturity, and therefore requires more significant 
psychological support. In the literature, few patients from 8 to 15 years of age have 
demonstrated this procedure’s feasibility [11]. Patients under the age of 10, chosen 
for this procedure, must demonstrate a rigorous level of maturity and motivation, 
so the child’s degree of development will determine the possibility of exercising this 
technique [10].
Multidisciplinary assessment (Pediatric neurosurgeon, Neuroanesthesiologist, 
Neuropsychologist, and Neurophysiologist) is indispensable to mitigate the patient’s 
stress. Some authors prepare the patient psychologically using videos and teaching 
material to explain the procedure. The previous visit to the operating theater can be 
an excellent option to gain the child’s trust and confidence [12, 13].
The Neuroanesthesiologist should know the surgical and neurophysiological needs 
required for this procedure. We have a wide variety of anesthetics that can be useful 
but should be individualized to each patient. Propofol, remifentanil, dexmedetomi-
dine, and scalp nerve blockage provide the right conditions for intraoperative brain 
mapping. Proper patient selection, adequate perioperative psychological support, and 
correct anesthetic management at each stage of surgery are all crucial for the safety, 
satisfaction, and success of the procedure. All of them must allow analgesia and a 
required sedation level according to the surgical moment [10]. It should be empha-
sized that certain anesthetics may affect the neurophysiological evaluation [12].
The neuroanesthesiologist should describe the procedure to follow, including 
position, scalp nerve blockage, possible discomfort, motor, and language testing. It 
would help to relieve the patient’s anxiety and discomfort and to ensure the surgery’s 
success [13, 14].
There are different craniotomy techniques in an awake patient, but Sleep-
Awake-Sleep (SAS) is the most convenient in pediatric patients for its cognitive 
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characteristics. Regardless of the technique chosen, the Neuroanesthesiologist or 
the person designated for the case must always maintain visual and verbal com-
munication throughout the procedure. The communication at each stage should 
be clear, and according to the patient’s age, questions and tasks should be planned 
to consider, explain what the sensation may be, explain the noises of the room 
and maintain an adequate distraction of the patient to avoid anxiety. Heavy traf-
fic within the room should also be avoided, limit staff access, and minimize room 
noises that confuse the patient which may cause anxiety. (4) Cooperation will 
depend on the total absence of pain, leading to an outstanding surgical experience; 
this is based on the anesthetics offered during the procedure, including efficient 
regional anesthesia with scalp blockage [15].
The premedication should be personalized according to each patient’s needs; 
short-lived anxiolytics such as midazolam is preferred. It does not affect neurocog-
nitive functions and limits confusion or delirium during the procedure. Minimum 
doses (100-200mcg/kg) are beneficial for controlling anxiety in young patients 
with normal preoperative neurological functions. However, in the case of mapping 
and resection of epileptogenic lesions, any suppressive medication of epileptiform 
and anticonvulsant activity, including benzodiazepines and barbiturates, should be 
avoided [16].
Analgesia during awake craniotomy is achieved by blocking nerves in the scalp 
with local anesthetics. Therefore, the patient’s hemodynamic and physiological state 
may be more stable in awake craniotomy than in general anesthesia [13].
The first phase of surgery may be performed with total intravenous anesthesia 
and a supraglottic device. There are current reports of possible adverse effects of 
general anesthetic agents, including inhaled agents and opioids, on cancer progno-
sis, such as increased recurrence or metastasis after surgery [14].
Anesthesiologists should provide sufficient sedation and analgesia during the 
initial craniotomy; a combination of remifentanil and propofol has been considered 
the standard protocol for sedation of the first stage of awake craniotomy due to 
ease of use and reliability. The state of drowsiness but with a quick response, is 
considered the optimal level of sedation in awake craniotomy. Schneider’s model is 
recommended for propofol’s controlled infusion into awake craniotomy to maintain 
patients’ spontaneous ventilation [17].
Dexmedetomidine, an alpha-2 agonist, is a propofol alternative for sedation in 
such procedures, minimally interferes with neurophysiological monitoring, and it 
also has a minimal respiratory depressant effect. Concomitant dexmedetomidine 
with scalp blockage provides sufficient conditions for performing awake crani-
otomy, compared to the propofol-remifentanil combination and the increased risk 
of respiratory depression [13].
Complications of awake craniotomy include seizures (3–30%), respiratory 
depression or airway obstruction (7–16%), hypertension (17–24%), nausea and 
vomiting (0–9%), cerebral edema (7–14%) [18, 19]. In expert hands, the failure of 
awake craniotomy occurs in less than 2% of cases, regardless of the proper anes-
thetic technique carried out [18, 20].
Monitored anesthesia care involves keeping the patient awake under spontane-
ous breathing with low doses of sedative to resection the lesion by avoiding an acute 
transition from sleep to wakefulness, leading to hypoactive or hyperactive delirium 
and decrease mapping reliability [19]. The team’s skill and experience are required 
to achieve optimal sedation, maintaining spontaneous breathing with the patient 
drowsy but easily reactive [21, 22].
Advantages: Lower requirements for anesthetic agents, lower opioid use, better 
cooperation during intraoperative testing, shorter surgery duration, and shorter 
hospital stay.
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Disadvantages: Oversedation leading to airway obstruction with respiratory 
depression, carbon dioxide (CO2) retention, and consequent cerebral edema; or sub-
optimal sedation that leads to the patient’s likelihood of anxiety and movements [21].
The SAS technique is preferred in cases of requiring more profound sedation 
during the craniotomy until before the resection of the tumor, and its objectives are 
to provide comfort for the patient and the surgical team during the pre-awakening 
phase, protection of painful sensations, to avoid ventilation distress, and to dismiss 
postoperative memories about the awake phase throughout the surgery [19].
Advantages: Provides the opportunity to control brain edema through hyper-
ventilation, to avoid intraoperative movements of the patient, to lower frequency 
of seizures and agitation. Used during the implementation of this technique in new 
hospitals or during the surgical team’s learning curve [8].
Disadvantages: In high-risk patients with comorbidities, difficult airway 
predictors, or a high risk of bleeding; the SAS technique is controversial [21].
3.1 Anesthetic depth monitoring in awake craniotomy
Researchers compared the Patient State Index, Masimo’s PSi, an electroen-
cephalogram (EEG) parameter obtained from SedLine’s brain function monitoring 
system® with Medtronic’s Bispectral Index (BIS™) for anesthetic depth monitor-
ing, found that PSi 1.0 was less affected by monopolar Bovie device [23].
Both can be used to monitor anesthetic depth trends in the Sleep-Awake-Sleep 
phase, to achieve an early and gentle awakening of total intravenous anesthesia [24]. 
The use of processed electroencephalography indices improves anesthetic titra-
tion in the intraoperative period. Processed EEG monitors deliver raw stroke data, 
numerical anesthesia/sedation depth index, and 2D spectrogram. Deep sedation is 
associated with poor short- and long-term outcomes in critical patients; cognitive 
and psychological complications, increased hospital stay and mortality [25].
The use of processed EEG systems as an objective guide to sedative dosing, may 
decrease medical complications of excessive sedation, such as depressed cardiac 
contractility and hypotension. BIS’s use provides a decrease in the use of sedation, 
analgesia, decreased agitation, and fewer failures in extubation.
Processed electroencephalogram can help optimize drug doses in individuals 
with different pharmacogenomics and sedative clearance; global knowledge of 
the technology and processed EEG traces is required to avoid misinterpretations, 
significantly when muscle activity interferes with the processing algorithm [26].
Some pathological states, such as seizures or altered EEG states (Suppression of 
iatrogenic bursts or seizure coma), may be revealed by processed EEG and thus a 
complete EEG may be requested [27].
PSi values can range from 0 to 100; higher values indicate a lower degree of seda-
tion as follows: 0–24 outbreak suppression with varying degrees of suppression, 25–49 
general anesthesia, and > 50 mild sedation [23]. The algorithm uses specific frequency 
band performance power combined with symmetry and synchronization changes in 
multiple cortical regions [24]. Without a doubt, processed EEG systems are an excel-
lent tool to optimize sedation and plan proper awakening in awake craniotomy.
4.  Electrocorticography and brain stimulation for brain tumor resection 
in the awake pediatric patient
Neurophysiological brain cortical mapping is a valuable tool for brain tumor 
resection by optimizing the extent of resection and minimizing or avoiding a 
neurological deficit. In the context of resection of supratentorial malignancies, 
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the gross-total resection improves survival, and by the usage of brain mapping, 
the functional outcome and quality of life are safeguarded in the postoperative 
period [28].
4.1 Principles
Stimulation can be bipolar or monopolar. In bipolar stimulation, the cathode 
and anode are at the level of the selected tissue. It is made using a grid of electrodes, 
deep electrodes, or an intraoperative manual stimulator (Figure 1).
The electric field produced is confined to a small area, usually half the distance 
between the electrodes, having a low risk of distal activation. Stimulation does not 
occur unless the electrodes are set directly over the tract, activating the axon’s initial 
part and its Ranvier nodes, where the most sodium channels are contained. Bipolar 
stimulation in cortical mapping and the technique described by Penfield and 
Ojemann, are the most commonly used [29, 30].
The standard stimulation paradigm for cortical stimulation described by 
Penfield, is based on applying a rectangular two-phase pulse with a frequency of 
50 Hz on trains lasting 3 to 5 seconds. Pulse duration remains constant at 0.3 ms, 
starting with an intensity of 1 mA, which increases from 1 mA waiting for a 
response to stimulation, to a maximum of 15 mA. When using the depth elec-
trodes, the pulse intensity is diminished to a range of 0.5–2.5 mA. In contrast, in 
monopolar stimulation, a single electrode administers the stimulus, and another 
reference electrode, usually inserted into the temporal muscle, receives it. The 
stimulus field is diffuse, and the volume of brain tissue is more significant, with 
the possibility of activating numerous axons in the motor pathways at a distance 
of 20 to 25 mm from the stimulation point. It is generally used for subcorti-
cal tracks and is known as the High-Frequency Train Technique or Taniguchi 
Technique [31].
This technique can be used for subcortical functional monitoring in patients 
under the effect of general anesthesia. A five-pulse monopolar train is typically 
administered at frequencies between 300 and 500 Hz, with a repetitive frequency 
Figure 1. 
Principal characteristics of electrodes for brain mapping and bipolar stimulation.
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of 1 to 3 Hz, including a pulse duration of 0.5 milliseconds and a range between 
stimuli of 2 to 4 milliseconds (Figure 2). This method is used to assess motor 
pathways and can also produce motor responses at lower intensities. It is not 
affected by the preoperative motor state, and the possibility of post-stimulation 
discharges is low.
The register is carried out through the potential evoked motor with electrodes 
placed in the contralateral limb muscles, such as the abductor pollicis brevis, 
the flexor, and forearm extender, which are usually good options for the upper 
extremity. In contrast, the abductor hallucis brevis is the best muscle in the 
case of the lower limb. For facial muscles, we have as options the orbicularis 
of the mouth and eyes, and the genius, which allow us to register the language 
articulation.
4.2 Indications
The intraoperative functional mapping in awake patients is directed to those 
with neoplastic or epileptogenic diseases located adjacent to the motor, visual, 
somatosensory, or language areas. We require patient cooperation to detect the 
change or deficit of their cognitive functions by stimulation during the procedure. 
Monitoring cortical and subcortical regions, allows us to resect brain tumors near 
eloquent cortical and white matter tracts, respectively, at the same surgical event. 
The limitation is that we have little time to perform the cognitive tasks necessary for 
transoperative assessment. It could represent an anesthesiological challenge because 
of the technical difficulty of performing a craniotomy in the awake patient and the 






General Considerations. Patients are premedicated with midazolam. The 
surgeon performs local anesthesia with a mixture of 1:1 bupivacaine at 0.5% and 
lidocaine at 1%; 1:100000 epinephrine for infiltration upon placement of the 
Mayfield’s head clamp. Sedation is performed by means of propofol (above 100 ug/
kg/min) and remifentanil (0.05–2 ug/kg/min). Once the craniotomy is completed, 
the dura mater and the muscle are infiltrated with lidocaine, and no sedation is 
offered. At all times of the mapping, propofol and icy ringer solution should be 
ready to use to suppress post-stimulation discharges. Once the mapping is finished, 
sedation is carried out with dexmedetomidine (1 ug/kg/min) and remifentanil 
(0.05 ug/kg/min) [32].
In the case of monitoring asleep patients, the purpose of mapping is exclusively 
to monitor motor response, so that short-acting opioids, such as remifentanil, 
supplemented with propofol or dexmedetomidine, are used. Almost all agents 
inhaled at high doses suppress motor responses, so it is suggested to use at low doses 
(less than 0.25 MAC), with nitrous oxide being the least suppressive. Propofol, 
commonly used for mapping, can suppress the motor response between 30 and 
60% at levels of 1 to 2 mg/ml, so it is suggested at 1ug/ml doses. Other agents, such 
as ketamine, opioids, benzodiazepines, have minimal effect on motor responses. 
The most commonly used scheme is a short-acting opioid with propofol or 
dexmedetomidine.
Other factors to consider in surgery include temperature, blood pressure, oxygen 
saturation, and CO2. Hypothermia (less than 35 degrees) or hyperthermia (greater 
than 38 degrees) can increase the motor response latency, decrease amplitude or 
suppress it altogether. Hypercapnia (greater than 70 mmHg) and hypocapnia (13 to 
30 mmHg) can alter mapping and promote cerebral edema.
Due to late myelinization, larger intensities of 15 mA and a longer stimulus 
duration of 500 ms are recommended in pediatric patients. It is suggested that the 
minimum age for evaluating language should be ten years old and for motor evalu-
ation a minimum of 5 years. In case the patient does not cooperate and needs to 
remain under general anesthesia, the monopolar subcortical stimulation technique 
is recommended, where a stimulus is administered with a train of five monopolar 
pulses at frequencies typically between 300 and 500 Hz, with a repeat frequency 
of 1 to 3 Hz including a pulse duration of 0.5 milliseconds, and an interval of 2 to 4 
milliseconds between stimuli.
4.4 Functional mapping
Once the craniotomy is performed and exposed to the cerebral cortex to map, 
the bipolar stimulation already described is carried out:
Pulse Biphasic
Frequency 50 Hz




Current intensity Increase 0.5–1 mA
Maximal current intensity 10–15 mA
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The stimulus should be applied at least three times; it is considered positive 
when at least 2 out of three times an answer is found. Responses can be either posi-
tive (regional movements, dysesthesias, phosphenes) or negative (motor inhibition, 
language alteration, anomia) (Table 1).
Language tasks such as nomination, articulation, reading, counting, and 
comprehension are evaluated. It is stimulated with a pulse duration of 0.25 ms on 
trains from 4 to 60hz, usually used from 1.5 mA and increased to 6. The stimula-
tion is applied from one to two seconds during the completion of the task. The 
point is stimulated at least three times. A positive point is considered when a 
66% language error is observed, such as the absence of language, anomia, and 
paraphasia. Some authors [30, 33, 34] have established the 10–20 mm concept as 
a safe margin, i.e., the distance from the resection edge to the mapped language 
site, in order to determine the risk of language deficits during the postoperative 
period. Usually, if this distance is greater than 1, the risk of language deficit in the 
frontal lobe is low.
4.5 Functional mapping considerations
The limitation of the technique is associated with several factors:
Brain 
function
Anatomic stimulation Clinical response
Motor Primary motor cortex (Brodmann 4): precentral 
gyrus, 10 mm anterior to the central sulcus and 
posterior region of central sulcus.
Contralateral muscle contraction.
Supplementary sensitive-motor area: dorsal 
region of the superior frontal gyrus.
Limb movements vocalization and 
contralateral cephalic movements.
Silent primary motor cortex: inferior or medial 
frontal gyrus.
Supplementary motor cortex: mesial surface of 
the superior frontal gyrus, paracentacral lobule 
and cingulum gyrus.
The negative response inhibits the 
motor response in the awake patient.
Sensitive Sensitive primary cortex (Brodmann 3,1,2): 
poscentral gyrus.
Contralateral paresthesias o 
dysesthesias.
Language Expressive language (Broca’s area): posterior 
region of the inferior frontal gyrus in dominant 
hemishere.
Posterior region of medial frontal gyrus, and 
anterior region of superior temporal gyrus in 
dominant hemisphere.
Negative response or language 
disturbances when the patient is asked 
to read, count numbers, or repeat 
sentences.
Sensitive language (Wernicke’s area): posterior 
temporoparietal area or temporal basal area of 
language (Inferior temporal gyrus, fusiform or 
hippocampal gyrus).
Negative response; alterations in 
understanding. Visual confrontation 
and nomination pictures.
Visual Primary visual cortex (Brodmann 17): occipital 
cortex.
Contralateral phosphenes and 
disturbances in perception of shapes, 
colors, or lines.
Secondary visual cortex (Broadmann 18) and 
secondary association cortex (Brodmman 19).
Visual illusions.





Cortical areas to stimulate during functional mapping.
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a. Patient’s condition. Previous deficit. These include a pre-existing deficit; 
usually the most accurate responses are obtained in patients with preserved 
motor and language functions. Any significant variation in sensation, motor 
paresis, or alterations of language or anomia, will not allow an appropri-
ate check-in in those areas. Patient’s age. Reduced myelination in pediatric 
patients, so motor responses are typically more challenging to activate than the 
standard parameters used in adults. Due to incomplete functional maturation, 
the motor and language areas can be identified with confidence after 5 and 
10 years old, respectively. Some suggested strategies to improve motor moni-
toring include pulse duration as large as 500 microseconds and increasing load 
intensity (more than 25 mA); this has been observed in children between 5 and 
7 years old, but as they grow and enter adolescence, they get thresholds similar 
to adulthood. One option for pediatric patients who cannot perform awake 
functional mapping, is to use other techniques such as primary motor cortex 
localization using the reserve phase technique, which indirectly allows us to 
locate the motor area (Figure 3).
b. Effect of different types of brain injuries. Pre-existing injuries, i.e., brain 
edema, hemorrhage, herniation syndromes, can increase stimulation thresh-
olds. The restoration of local homeostasis improves the stimulation threshold. 
Moreover, modification in the functional expressiveness of cortical areas due 
to the mass effect secondary to neoplasms. In patients with cortical malfor-
mations such as dysplasia, an abnormal somatotopic organization is observed 
and induces several secondary mechanisms, leading to a compensatory 
reorganization known as neural plasticity [35].
Figure 3. 
Reverse-phase. An electrode grid is applied to identify the motor and somatosensory primary cortex.  
A) Parietal lobule exploration. B) Neurophysiological typical response for somatosensory cortex stimulation. 
C) Electrode-grid relocation to identify primary motor cortex. D) Reverse-phase demonstration.
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4.6 Technical limitations
4.6.1 Lack of standardization
Negative mapping does not protect and creates a questionable problem concerning 
the reliability of the stimulation. There is a lack of consensus on stimulation para-
digms and techniques. Significant variations were observed, not only in stimulation 
environments, but also in proven functions and protective margins preserved in resec-
tion. An example is deficit in language functions after functional mapping. In the sur-
vey, several centers where the functional mapping is practiced, only half responded 
that they regularly tested the four commonly checkable functions (speech production, 
comprehension, denomination, reading), creating the possibility of false-negative 
results related to unproven function. It may explain why 41% of centers reported 
persistent postoperative language deficiencies despite the preservation of language 
areas, and 56% of this group mentioned the failure to identify crucial language sites 
[28]. Variability in mapping thresholds has been observed not only at the popula-
tion level but also in individual patients. One maneuver to facilitate the response in 
eloquent areas could be to increase the current at each cortical site, regardless of the 
adjacent post-estimate discharge threshold, instead of mapping the entire exposed 
cortex into a single current level. Besides, their findings highlighted the need for ECoG 
during electrocortical stimulation mapping, both to identify when post-stimulation 
discharges occur and to verify stimulation by recording stimulation artifacts [36].
4.6.2 Post-stimulation
Post-stimulation discharges can evolve into seizures during the surgical proce-
dure, which is why the anesthesiologist should always be ready with propofol as well 
as the surgeon with an icy ringer solution. These stimuli thresholds are not signifi-
cantly higher than those used to stimulate sensory, motor, or linguistic responses. 
However, post-stimulation discharges have been reported during awake craniotomy 
at 12% [37, 38].
4.6.3 Anesthesiologic challenge
From an anesthetic perspective, cortical functional mapping with an awake 
patient imposes essential demands on the anesthesiologist ability to facilitate sleep-
awake-sleeping procedures and avoid inadequate or excessive sedation. Pain, emesis, 
and emotional intolerance to the technique are rarely observed, and, of course, 
seizures can occur. Failure of the functional cortical mapping technique leads to a 
lower macroscopic total resection incidence and increased postoperative morbidity.
4.7 Intraoperative electrocorticography
4.7.1 Objectives and limitations of intraoperative electrocorticography
Epilepsy surgery involves complete resection of the epileptogenic area (the 
alleged site generating epileptic seizures, removal or disconnection is neces-
sary in order to prevent further seizures) with minimal postoperative deficits. 
Electrocorticography (ECoG) allows the epileptogenic zone to be delimited using 
flexible electrodes placed before and after resection, and to use the electrodes to 
stimulate and delimit the eloquent area. However, sampling is limited by reduced 
registration time during surgery [39].
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So ECoG is not sufficient to define the epileptogenic zone; many preoperative 
studies are required, such as video-EEG, functional and structural MRI including 
PET, SPECT, and sometimes invasive recording with grid placement. The ECoG 
intraoperative utility as a single element for defining the epileptogenic zone in a 
reliable way, is based on the assumption that interictal discharges are trustworthy 
markers of the epileptogenic zone. This assumption has proven unreliable in many 
cases. One of the most significant transoperative electrocorticography limitations is 
that primary epileptiform discharges may not be identified from secondary ones by 
propagating to a distant area. More importantly, ECoG’s in patients with refractory 
epilepsy to medical treatment has shown interictal multifocal activity, making focus 
identification a difficult task.
Interictal activity may be affected by anesthetic agents use, as some of those 
agents decrease activity while others increase them. It is said that the log is reliable 
when a pattern of awake interictal poly points is observed with a tip frequency 
exceeding one per minute. Some activation maneuvers, such as hyperventilation 
or some intravenous anesthetics such as methohexital, etomidate, propofol, and 
thiopental, have been used.
Unfortunately, the activation induced by these agents could be expanded to 
previously silent areas. Opioids, such as remifentanil and alfentanil, increase the 
activity in the epileptogenic zone. Remifentanil has been reported to suppress tips 
in the normal brain.
Other attempts have been made to locate the epileptogenic area using repetitive 
cortical electrical stimulation and evaluate its susceptibility to start a discharge 
and reproduce the patient’s usual seizure. Although early researchers expected 
post-stimulation discharges originating in the epileptogenic area to have distinctive 
characteristics (lower post-discharge thresholds and longer durations), this is not 
true. The use of electrical stimulation to induce the patient’s usual seizures has also 
shown not to be useful.
Three types of electrodes are used to register intraoperatively, often in combination:
The first type consists of silver wires insulated with a carbon ball or a distal sil-
ver ball/silver chloride located on the cortical surface. These electrodes are arranged 
in an electrode clamping device mounted on the skull at the edge of the craniotomy 
and attached to the recording device inputs. Although flexible and precise electrode 
placement, particularly along the resection cavities, is an excellent resource of this 
type of electrode; the exact distance between electrodes can be problematic, limit-
ing the ability to engrave in a bipolar assembly. Therefore, recording in a reference 
montage is preferred. Also, electrode placement is limited only to the cortex areas, 
so it is impossible to register from the lower and medial surfaces. These electrodes 
can be sterilized and reused.
The second type of electrode is disposable and consists of silver stainless steel, 
or platinum disc electrodes embedded in silicone sheets. These blades are arranged 
in advance as strips containing 4 to 8 electrodes, with a separation of 10 to 15 mm, 
or larger grids containing 64 electrodes or more. These electrodes can be placed on 
the exposed cortical surface and allow the flexibility to slide under the craniotomy 
margins to cover the cortex uncovered surfaces. Because the distances between 
electrodes are standardized, it is possible to make recordings in both bipolar and 
referencing assemblies. However, due to the potential for cancelation of common-
mode activity under two adjacent electrodes in a bipolar recording, referencing 
assembly remains preferred and universally accepted as being more reliable. 
Functional stimulation can also be performed through band and grid electrodes.
Finally, a four-contact depth electrode can also be used to be inserted into the 
brain’s deeper structures. It is not uncommon for these various electrodes to be used 
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simultaneously, with ball electrodes used to register over the lateral cortex or along 
the resection margins, while electrode strips are placed in the cortical areas. The 
recording electrodes can be referenced to several locations, including the mastoid, 
cervical, and bone flap region.
The ECoG can be registered using digital or analog instruments, although digital 
has become more used. As the activity recorded on the cortical surface is signifi-
cantly higher than the one recorded on the skin surface, the recording parameters 
must be adjusted. Sensitivities between 10 and 50 mV/mm are the most commonly 
used. Other recommended recording parameters include a 0.5 Hz low-frequency 
filter and a 70 Hz high-frequency filter.
The usefulness of electrocorticography in anteromedial temporal lobectomy 
allows delimiting the degree of resection of the hippocampus. The most significant 
cause of seizure recurrence after temporal lobectomy is the incomplete resection 
of the affected hippocampus. Therefore, the resection of the hippocampus guided 
by electrocorticography has been the only procedure with a predictive value. Its 
usefulness has also been seen in patients with refractory epilepsy to extratemporary 
location medical treatment, where the need for all patients to require an invasive 
chronic record is controversial.
In patients with a high concordance between neuroimaging (MRI, PET, and 
SPECT) and the clinic of seizures, although EEG may not be conclusive in identify-
ing the ictal area, it is indicated to perform the resection of the epileptogenic focus 
in a single surgical time guided by electrocorticography.
Electrocorticography is very useful in the resection of structural lesions that 
generate seizures, such as low-grade astrocytomas or malformations, and the sur-
rounding epileptogenous cortex. Patients who had only the lesion resection, have a 
probability of being free of crisis by 50% and increasing to 87% when electrocorti-
cography is offered.
Electrocorticographography has been very useful in cortical dysplasia resec-
tion, where sometimes the image is not very clear, especially in type I cortical focal 
dysplasias, and where electrocorticography helps define the edges of the margins of 
the resection.
Finally, ECoG should be used during functional mapping to detect post-stimulus 
discharges that can occur over a wide threshold range (2 to 15 mA), usually lasting 
seconds, but some downloads last more than 90 seconds. Post-stimulus discharges 
have been present in 12% of patients undergoing cortical functional mapping; 65% 
of these discharges involve more than one electrode, and 10% become epileptic 
electrographic activity.
5. Clinical experience
Since 2017, we have performed awake craniotomies and brain mapping for 
brain tumor resection in 8 and 5 cases, respectively. The average age of patients 
was 12.2 years old with a range of 10–15 years old. No gender predominance was 
observed (Male/Female ratio 1). The neuropsychological evaluation was performed 
in all cases. A series of neuropsychological tests were applied to meet the matu-
rity and neurological performance in all cases. Before considering each case as a 
candidate for an awake craniotomy, an assay was conducted by the neurosurgeon 
and the neuroanesthesiologist to gain the patient’s confidence. In all cases, the 
technique was completed. In some cases, conversion to total-endovenous anesthesia 
was necessary. Intraoperative seizures were not observed during brain mapping or 
stimulation of eloquent areas in the neighborship of brain tumors.
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In order of frequency, the most common histopathological diagnosis was diffuse 
glioma (n = 3), supratentorial glioblastoma multiforme (n = 2), dysembryoplastic 
tumor (n = 2), and Primitive Neuroectodermal Tumor (PNET) (n = 1). In all 
cases, gross total resection was achieved. In malignant gliomas, the overall survival 
was 32 months. In this group, all patients received adjuvant chemotherapy and 
radiotherapy. In the cases of diffuse glioma, we have not observed fatalities so far. 
Currently, the overall survival is 38 months. In the case of PNET, adjuvant therapy 
and radiotherapy with a linear accelerator were indicated. The free of disease period 
was 18 months, a new surgical treatment was indicated to improve survival, but 
in the postoperative period, the patient’s family declined the second-line chemo-
therapy, and the patient died after 28 months— Case 1 VIDEO.
In all cases, during follow-up, we observed a clinical improvement of 
neurological deficits. In the two cases of epilepsy secondary to brain tumor 
activity – dysembryoplastic tumor, the cortical mapping and brain stimulation 
in eloquent areas improved the seizure control and functional recovery in the 
postoperative period. In one of these cases, after the tumor’s gross-total resec-
tion, a new ECoG helped us identify epileptic activity isolated from the brain 
tumor. Histopathological analysis revealed cortical dysplasia. After removing the 
epileptic foci by corticectomy, the new ECoG register showed regular electrocor-
ticographic activity — Case 2 Currently, the two patients with dysembryoplastic 
tumors are seizure-free (Engel’s class Ia).
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6. Conclusions
The SAS technique is a reproducible, safe, and probably the most convenient 
technique for awake craniotomy in pediatric patients with brain tumors. It is 
imperative to maintain good communication with the patient from pre-anesthetic 
assessment, explaining the most confident procedure. SAS will provide the most 
outstanding comfort before awakening and during neuropsychological and motor 
tests, recognizing that the neurological evaluation during and after the surgical 
procedure will be the best indicator of the patient’s condition and success.
Cortical functional mapping allows us to delimit lesions that require resection, 
such as an epileptogenic zone or a tumor from eloquent regions. For this purpose, 
with a mature and cooperative patient, surgery may be performed with an awake 
patient. This technique is reserved for patients without severe neurological deficits 
in order to preserve the language, somatosensory, or motor functions. If the patient 
does not cooperate, as are pediatric patients below eight years old, the cortical func-
tional mapping for motor functions could be performed with general anesthesia.
Electrocorticography is widely used in epilepsy and brain tumor surgery. Its 
usefulness has also been seen in patients undergoing temporary mesial lobectomy 
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to determine the hippocampus degree of resection. Another utility is in resective 
surgery for structural lesions that cause seizures (tumors, cortical, vascular malfor-
mations), in order to delimit the surrounding epileptogenic zone and expand it.
Finally, electrocorticography must be accompanied by the mapping procedure to 
identify post-stimulation discharges.
7. Clinical cases
Case 1. An 8-year-old boy presented at the emergency department with a two-
month history of headache, left-sided weakness (1/5), and generalized seizures. 
MRI study shows a premotor right brain tumor (A). An awake craniotomy was 
performed, and gross total resection was achieved. VIDEO. (https://bit.ly/3vXzr2S) 
(C). The pathology service reports a Primitive Neuroectodermic tumor. The patient 
receives chemotherapy (Iphosphamide - Carboplatine - Etoposide) and radiother-
apy 54 Gy (Lineal-accelerator). During follow-up, a recurrence was suspected (D), 
and a new surgical treatment was performed (E).
Case 2. A 4-year-old female presented to the neurosurgery department with 
a history of symptomatic epilepsy since she was 3 years old. A few months later, 
autism disorder was detected. Partial motor seizures with hand-forearm-shoulder 
involving and secondary generalization were observed. An MRI study was 
performed, and a neoplastic lesion in the primary motor cortex was identified. 
A comprehensive case review was performed. Because of the history of autism 
disorder, the patient was dismissed as a candidate for awake craniotomy. However, 
she was considered a candidate for surgical treatment by total endovenous anes-
thesia. The primary motor cortex was identified with the reverse-phase technique 
in the operating room, and transoperative electrocorticography was performed. 
The gross-total resection was achieved for the brain tumor, and a subpial resection 
was completed after the identification of epileptic foci identified by a new ECoG. 
A) Preoperative MRI. B) ECoG to define the epileptic activity. C) ECoG after brain 
tumor resection. D) ECoG identifies epileptic activity in the rostral region of pars 
triangularis. E) After subpial resection of epileptic foci. F) Follow-up MRI.
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